Video

'Knowledge is Power' in Genetic Testing for Hereditary Cancer

Having the right understanding and information of a patient’s genetics can not only help treat cancer but also help prevent it.

Patients who are unsure about undergoing genetic testing but may have a genetic predisposition to cancer should consider the positive impact their results may have on their health, whether they have been diagnosed or not, according to Dr. Lauren Carcas.

Carcas, a medical oncologist from the Miami Cancer Institute, recently sat down with CURE® at the 37th Annual Miami Breast Cancer Conference® and CURE® Educated Patient Breast Cancer Summit to talk about the importance of genetic testing, and how it can inform treatment decisions in individuals with cancer.

Transcription:

I always argue that knowing family history is arguably one of the most important things to know about what your risk is for breast cancer. I think that genetic testing is a situation of “knowledge is power”.

If you know your risk, you can potentially take action to reduce that risk, potentially nearly eliminate that risk. But if you already have a diagnosis of breast cancer, it’s really important because that actually might impact your treatment decision.

Really, you have to be your own advocate, and part of advocating for yourself is knowing the total history and knowing the total diagnosis. Knowing that you have a gene mutation that is the underlying cause of your diagnosis is really important.

Related Videos
Image of Doctor with blonde hair.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Related Content